COVID-19 vaccine-induced cellulitis and myositis
Sathishkumar Ramalingam, Harkesh Arora, Susan Lewis, Kulothungan Gunasekaran, Maheswari Muruganandam, Sivakumar Nagaraju, Priyesh Padmanabhan
Abstract
<b>SUMMARY:</b> Acute stroke intervention is rapidly evolving. New technologies are improving device deliverability and rates of recanalization. We describe 2 cases of acute middle cerebral artery occlusions wherein Wingspan stents could not be delivered to the occlusive site because of excessive vascular tortuosity. Merci thrombectomy was also unsuccessful. Revascularization was only achieved with deployment of the highly navigable Enterprise stent, resulting in thrombolysis in myocardial infarction 2/3 flow. Thus, all devices should be considered in the armamentarium of stroke therapy.
Topics & Concepts
MedicineMyositisCoronavirus disease 2019 (COVID-19)Cellulitis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyDermatologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchDermatological and COVID-19 studiesRetinal and Optic Conditions